Breast Cancer Drugs

submitted: Jul 19th 2008 | by: RayLam | Total views: 1 | Word Count: 292 | PDF View | Print Article

Raloxifene and breast cancer. There has been a great deal of press interest recently in whether the osteoporosis drug Raloxifene can have an impact on the outcome for breast cancer patients. But what's the evidence? Does this drug reduce the risk of invasive breast cancer?

The recent press reports all related to an extracted subgroup of patients from another research project. That trial was designed to look at heart disease - not breast cancer - but the data was re analysed and extrapolated to look at breast cancer in some of the women who took this medication. The study seems to show that the drug reduces the risk of invasive oestrogen-receptor positive breast cancer in these women, regardless of any underlying risk factors

Dr. Gary M. Freedman, a radiation oncologist at the Fox Chase Cancer Center in Philadelphia said,"There's still a lot of questions that remain, but this study confirms that five years of tamoxifen alone is really becoming the wrong answer for most postmenopausal women. At this point, you have to say that aromatase inhibitors are in the mix of treatment at some point."

But is there a place for the medication in the prevention of new breast cancer cases? That answer still remains elusive so we don't know if it should be given to healthy women as a way of reducing breast cancer risk.

Although this medication may go on to save the lives of many women, the FDA should not allow companies who have interest in the outcome of the study be the one who funds and conducts it. Anyone who has interest in the outcome of any event will always do what is in their power to protect their interest. Like the old adage goes. ?You ain?t cheatin, You ain?t tryin .?

About the Author

Learn about breast cancer organizations and get a limited FREE report on Latest Breast Cancer Drugs by visiting http://breast-cancer-remedy.info, a popular website that provides free breast cancer care advice.


Comments

No comments posted.

You do not have permission to comment. If you log in, you may be able to comment.